Pheochromocytoma and the normal adrenal medulla: improved visualization with I-123 MIBG scintigraphy
- PMID: 4001380
- DOI: 10.1148/radiology.155.3.4001380
Pheochromocytoma and the normal adrenal medulla: improved visualization with I-123 MIBG scintigraphy
Abstract
The radiopharmaceutical iodine 131 metaiodobenzylguanidine (I-131 MIBG) has been shown to locate pheochromocytomas scintigraphically with a false-negative rate of approximately 13%. To improve image quality and reduce the false-negative rate, I-123 was examined as a radioactive label for MIBG, as it has many advantages over I-131, including superior dosimetry and better detection efficiency. Diagnostic doses of 0.5 mCi (18.5 MBq) I-131 MIBG and 10.0 mCi (370.0 MBq) I-123 MIBG with nearly equivalent radiation dosimetries were compared in 18 patients with known or suspected pheochromocytomas. Images of superior quality were obtained with I-123 MIBG in 18 of 18 patients, and in eight cases lesions not visualized on I-131 MIBG scintigraphy were portrayed. A further advantage of I-123 MIBG is that it permits single photon emission computed tomography (SPECT). This was performed in six cases and provided additional information in three cases. The adrenal medullae were definitely visualized using I-123 scintigraphy in eight of 14 patients still possessing adrenal glands, whereas I-131 MIBG images portrayed the adrenal medulla in only one of 14 cases. Five remaining patients had multiple abdominal tumor deposits that were difficult to differentiate from normal adrenal medullae.
Similar articles
-
Iodine-131-MIBG scintigraphy in adults: interpretation revisited?J Nucl Med. 1998 Jun;39(6):1007-12. J Nucl Med. 1998. PMID: 9627334
-
Radioiodinated metaiodobenzylguanidine scintigraphy for pheochromocytoma. A false-positive case of adrenocortical adenoma and literature review.Horm Res. 1996;46(3):138-42. doi: 10.1159/000185010. Horm Res. 1996. PMID: 8894669 Review.
-
Portrayal of pheochromocytoma and normal human adrenal medulla by m-[123I]iodobenzylguanidine: concise communication.J Nucl Med. 1984 Apr;25(4):436-40. J Nucl Med. 1984. PMID: 6544815
-
[Diagnosis of pheochromocytoma by 131I-MIBG scintigraphy].Hinyokika Kiyo. 1990 Feb;36(2):105-8. Hinyokika Kiyo. 1990. PMID: 2343801 Japanese.
-
Pheochromocytoma: diagnosis by scintigraphy using iodine 131 metaiodobenzylguanidine.South Med J. 1991 Oct;84(10):1221-30. doi: 10.1097/00007611-199110000-00015. South Med J. 1991. PMID: 1925724 Review.
Cited by
-
Roles of cardiac sympathetic neuroimaging in autonomic medicine.Clin Auton Res. 2018 Aug;28(4):397-410. doi: 10.1007/s10286-018-0547-6. Epub 2018 Jul 30. Clin Auton Res. 2018. PMID: 30062642 Free PMC article. Review.
-
SPECT/CT and PET/CT molecular imaging in medullary thyroid carcinoma. Are we running in the right direction?Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1692-1694. doi: 10.1007/s00259-017-3757-6. Epub 2017 Jun 22. Eur J Nucl Med Mol Imaging. 2017. PMID: 28638977 No abstract available.
-
Fluorine-18-fluorodihydroxyphenylalanine Positron-emission Tomography Scans of Neuroendocrine Tumors (Carcinoids and Pheochromocytomas).J Clin Imaging Sci. 2017 May 22;7:20. doi: 10.4103/jcis.JCIS_107_16. eCollection 2017. J Clin Imaging Sci. 2017. PMID: 28584687 Free PMC article.
-
Diagnosis and management of pheochromocytoma: a practical guide to clinicians.Curr Hypertens Rep. 2014 Jul;16(7):442. doi: 10.1007/s11906-014-0442-z. Curr Hypertens Rep. 2014. PMID: 24792093 Review.
-
Pheochromocytoma and paraganglioma: current functional and future molecular imaging.Front Oncol. 2012 Jan 6;1:58. doi: 10.3389/fonc.2011.00058. eCollection 2011. Front Oncol. 2012. PMID: 22655253 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical